Find trials
Search tips

Endometrial Cancer/Endometrial Atypical Hyperplasia with an AI-based Classifier in Transvaginal Ultrasound in Patients with Post-Menopausal Bleeding

Overview

About this study

The purpose of this study is to prospectively validate a new Artificial Intelligence (AI)-based model developed by our team to analyze TVUS images for early EC detection.  

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Age ≥ 55 years.
  • At least one episode of PMB.
  • Endometrial biopsy to be performed at Mayo Clinic (MN, AZ, FL).
  • Acceptance to participate in the study.

Exclusion Criteria

  • Physical impediment/refusal to undergo TVUS.
  • Endometrial biopsy performed > 90 days after TVUS.

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Eligibility last updated 11/14/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Gretchen Glaser, M.D.

Open for enrollment

Contact information:

Krista Storing

(507) 266-3382

Teske.Krista@mayo.edu

Jacksonville, Fla.

Mayo Clinic principal investigator

Christopher DeStephano, M.D., M.P.H.

Open for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20564259

Mayo Clinic Footer